Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cario

Showing results (471-480 of 548) with videos related to

Pageof 55
Sort By:
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Communications Biology|January 16, 2021
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemiaLennart Lenk, Michela Carlet, Fotini Vogiatzi, et al.
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Blood|June 7, 2021
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemiaElena Boldrin, Enrico Gaffo, Alexandra Niedermayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
Blood|April 22, 2015
Central nervous system acute lymphoblastic leukemia: role of natural killer cellsLiron Frishman-Levy, Avishai Shemesh, Allan Bar-Sinai, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
Leukemia|August 6, 2022
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like diseaseJan Zuna, Lenka Hovorkova, Justina Krotka, et al.
Blood|June 1, 2017
Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in <i>thrombopoietin</i>Aaron Seo, Miri Ben-Harosh, Mehtap Sirin, et al.
International Journal of Cancer|March 27, 2020
PTPN11 mutations in canine and human disseminated histiocytic sarcomaBenoit Hédan, Mélanie Rault, Jérôme Abadie, et al.
Pageof 55

Showing results (471-480 of 548) with videos related to

Sort By:
Pageof 55
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Communications Biology|January 16, 2021
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemiaLennart Lenk, Michela Carlet, Fotini Vogiatzi, et al.
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Blood|June 7, 2021
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemiaElena Boldrin, Enrico Gaffo, Alexandra Niedermayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
Blood|April 22, 2015
Central nervous system acute lymphoblastic leukemia: role of natural killer cellsLiron Frishman-Levy, Avishai Shemesh, Allan Bar-Sinai, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
Leukemia|August 6, 2022
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like diseaseJan Zuna, Lenka Hovorkova, Justina Krotka, et al.
Blood|June 1, 2017
Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in <i>thrombopoietin</i>Aaron Seo, Miri Ben-Harosh, Mehtap Sirin, et al.
International Journal of Cancer|March 27, 2020
PTPN11 mutations in canine and human disseminated histiocytic sarcomaBenoit Hédan, Mélanie Rault, Jérôme Abadie, et al.
Pageof 55